Friday, July 30, 2021

Eris Lifesciences on the lookout for acquisitions of brands, product portfolios

Eris Lifesciences on the lookout for acquisitions of brands, product portfolios The company shortlists therapy segments such as cardio, diabetes, vitamins, neuro, dermatology and women#39;s health for buyouts. COO says there are opportunities coming from multinationals and large domestic companies.

from Moneycontrol Business News https://ift.tt/3rPZVla
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

S&P 500, Nasdaq end higher on Amazon-OpenAI deal; Fed path forward grows murky

Artificial intelligence deals propelled the S&P 500 and Nasdaq higher on Monday, with Amazon's $38 billion agreement with OpenAI and...